Invesco Ltd. Athenex, Inc. Transaction History

Invesco Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $12,224 - $27,132	-29,816 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.79 - $1.59 $323 - $650	409 Added 1.39%	29,816 $25,000
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $12,287 - $26,562	-9,035 Reduced 23.5%	29,407 $40,000
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $18,366 - $29,930	6,184 Added 19.17%	38,442 $115,000
Q2 2021 Aug 17, 2021	BUY	$3.71 - $5.13 $50,200 - $69,414	13,531 Added 72.25%	32,258 $149,000
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $15,822 - $57,200	3,878 Added 26.12%	18,727 $80,000
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $164,229 - $208,034	14,849 New	14,849 $164,000
Q3 2019 Nov 14, 2019	SELL	$12.16 - $21.0 $661,212 - $1.14 Million	-54,376 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $513,309 - $1.08 Million	54,376 New	54,376 $1.08 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.